Isocarboxazid is a non-selective, irreversible (covalent) monoamine oxidase inhibitor (MAOI) of the hydrazine class used as an antidepressant. Along with phenelzine and tranylcypromine, it is one of only three classical MAOIs still available for clinical use in the treatment of psychiatric disorders in the United States, though it is not as commonly employed in comparison to the others. Isocarboxazid is primarily used to treat mood and anxiety disorders. It has also been investigated in the treatment of Parkinson's disease and other dementia-related disorders. References: Larsen JK, Bendsen BB, Bech P. Vitamin B6 treatment of oedema induced by mirtazapine and isocarboxazid. Acta Psychiatr Scand. 2011 Jul;124(1):76-7; discussion 77. doi: 10.1111/j.1600-0447.2011.01695.x. Epub 2011 Mar 16. PubMed PMID: 21410439.

纯度：≥98%

CAS：59-63-2